Explore Stanford technologies available for licensing:

Prematurity is the single largest cause of death in children under 5 years of age, both in low-and high-income countries.

Researchers at Stanford have identified GPR84 as a new highly specific imaging biomarker of neuroinflammation and innate immune activation.

Stanford researchers have developed a technology that predicts deep brain activity from standard scalp EEG recordings.

Stanford researchers have developed a new machine learning method for extracting gait parameters, such as cadence, step length, peak knee flexion, and Gait Deviation Index (GDI), from a single video.

Stanford researchers have developed a fabrication method for laser patterning stretchable electronics.

Spiral ganglion neurons (SGNs) are essential for hearing as they transmit electrical signals from the cochlea to the brain. Loss of SGNs causes permanent hearing loss because SGNs do not spontaneously regenerate in humans.

Prof. Ron Levy's laboratory at Stanford developed a monoclonal antibody and hybridoma that targets CD37 (formerly known as MB-1). CD37 is expressed by mature human B cells in blood and tonsil, but not on T cells, thymocytes, granulocytes, or platelets.

MECA-99 is a previously unpublished EC-specific rat monoclonal antibody (mAb), which in most settings selectively stains capillary EC in adult mice.

Novel Endothelial Adhesion Molecule for Monocytes

Hemizygous mice are viable and fertile with no anatomic abnormalities. Transgene expression is observed in aorta, heart, and brain. Transgenicdimethylarginine dimethylaminohydrolase (DDAH) activity is reflected in a reduction of plasma asymmetric dimethylarginine (ADMA).

Stanford researchers at the Prakash Lab have developed Octopi, a low-cost ($250-$500) and reconfigurable autonomous microscopy platform capable of automated slide scanning and correlated bright-field and fluorescence imaging.

In nearly all current medical practice for treatment of infectious diseases, a single treatment dose is used for all patients.

Heart failure is a complex cardiovascular disease that affects 26 million people worldwide and is characterized by the inability of the heart to pump blood effectively, leading to a decline in its normal functions.

Stanford researchers have demonstrated clinical proof of concept that a real-time biofeedback system can reduce pain and slow joint degeneration in patients with movement disorders such as knee osteoarthritis.

Stanford researchers in the Bao Lab have developed damage-resistant stretchable electronic materials and devices that can be used in wearable electronics.